Your guide to EYLEA. aflibercept solution for injection. EYLEA is used to treat visual impairment due to Diabetic Macular Oedema (DMO)

Similar documents
Diabetic retinopathy - the facts

Facts about diabetic macular oedema

Avastin (Bevacizumab) Intravitreal Injection

Laser Treatment for Diabetic Retinopathy

Understanding posterior vitreous detachment

Patient Information Cataract surgery

Eye Diseases , The Patient Education Institute, Inc. otf30101 Last reviewed: 05/21/2014 1

Preparing for laser treatment for diabetic retinopathy and maculopathy

Oxford Eye Hospital. Vitrectomy. Information for patients

Alexandria Fairfax Sterling Leesburg

Which eye conditions can avastin injections be used for?

Macular Degeneration

Vitreo-Retinal and Macular Degeneration Frequently Asked Questions

Understanding eye conditions related to Diabetes

Information about cataract surgery

Patient information factsheet. Cataract surgery. Consent for cataract surgery

PATIENT INFORMATION BOOKLET

Cataracts. Cataract and Primary Eye Care Service Main Number Physician Referral AT-WILLS

Laser Treatment for Diabetic Retinopathy and Maculopathy

Guide to Eye Surgery and Eye-related Claims

HEALTHY EYES. Type 2 diabetes. Information for patients. Disease Management Programme

There may be no symptoms at first. Eye problems can. You can help prevent eye problems. Just because you have

Having a vitrectomy- surgery to

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT

Eye Injuries. The Eyes The eyes are sophisticated organs. They collect light and focus it on the back of the eye, allowing us to see.

If you forget to use Catacrom Eye Drops If you forget to use this medicine, use it as soon as you remember.

Phaco-endoscopic cyclophotocoagulation (phaco-ecp)

Information for patients attending appointments at King s College Hospital only

Selective Laser Trabeculoplasty (SLT)

Making Vision a Health Priority. Speaker s Guide

An Informational Guide to CENTRAL RETINAL VEIN OCCLUSION

Hopefully this information will be useful for people with dementia, their families, carers and medical professionals.

Local anaesthesia for your eye operation

Seeing Beyond the Symptoms

Get Your Eyes Examined

Cataract Information for Patients

Age- Related Macular Degeneration

Marketing Samples Medical Optometry

Epidural Continuous Infusion. Patient information Leaflet

Age-Related Eye Diseases and Conditions. See Well for a Lifetime

Laser Treatment of the Retina

Explanation of the Procedure

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE)

2 What you need to know before you have Ampiclox

Cataract and Cataract Surgery

This information explains the advice about type 2 diabetes in adults that is set out in NICE guideline NG28.

Laser Treatment for Proliferative Diabetic Retinopathy (PDR) Pan Retinal Photocoagulation (PRP)

Information About Your Day Care Cataract Operation

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

Understanding cataract. The Eye Service at Barts Health

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR ATRIAL FIBRILLATION

Your one stop vision centre Our ophthalmic centre offers comprehensive eye management, which includes medical,

Information For Consent For Cataract Surgery

Oregon Eye Specialists, PC YOUR GUIDE CATARACT SURGERY. Improving VISION. Improving LIFE.

Type 2 Diabetes. What is diabetes? Understanding blood glucose and insulin. What is Type 2 diabetes? Page 1 of 5

Information for adults undergoing squint surgery

How to care for your eye after surgery

Glaucoma filtration surgery (Trabeculectomy)

National Hospital for Neurology and Neurosurgery

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

Local anaesthesia for your eye operation

BREAST CANCER. How to spot the signs and symptoms and reduce your risk. cruk.org

The Radiotherapy Department Radiotherapy to the chest wall and lymph nodes

What do you know about HbA1C

The Doctor-Patient Relationship

How To Know If You Can See Without Glasses Or Contact Lense After Lasik

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

Getting the most from blood pressure medicines

Common Eye Conditions Explained

A PATIENT S GUIDE TO PULMONARY EMBOLISM TREATMENT

PRESSURE POINTS SERIES: Introducing high blood pressure

CATARACT SURGERY. Information Leaflet. Your Health. Our Priority.

Epidurals for pain relief after surgery

INFORMED CONSENT FOR CATARACT AND LENS IMPLANT SURGERY

Having a circumcision information for men

Dizziness and Vertigo

Understanding Diabetes

Headache after an epidural or spinal injection What you need to know. Patient information Leaflet

VISION LOSS EVERYTHING YOU WANTED TO KNOW BUT WERE AFRAID TO ASK!

NHS cervical screening Helping you decide

DIABETES. Eyes, Heart, Nerves, Feet, and Kidneys.

Having denervation of the renal arteries for treatment of high blood pressure

Leflunomide Leflunomide

Diabetes & blindness. due to DME BLINDNESS IN EUROPE

Secondary liver cancer Patient Information Booklet

Glaucoma filtration surgery (Tube surgery)

WELCOME TO COPPELL VISION CENTER

Insertion of a Peripherally Inserted Central Catheter (PICC Line)

ADJUSTABLE SQUINT SURGERY

National AMD & Low Vision Awareness Month- February Dr. Karuna Milind. Wellness Dept., Health India TPA.

A Carer s Guide to Depression in People with a Learning Disability

Information About Your Retinal Detachment Operation

After pelvic radiotherapy

Cerebral Palsy and Visual Impairment

Surgery for breast cancer in men

THE EYES IN MARFAN SYNDROME

A PATIENT S GUIDE TO STROKE AND ATRIAL FIBRILLATION (AF)

19235 N Cave Creek Rd #104 Phoenix, AZ Phone: (602) Fax: (602)

Type 2 diabetes Definition

Stanger Hospital Eye Care Centre.

Transcription:

aflibercept solution for injection Your guide to EYLEA EYLEA is used to treat visual impairment due to Diabetic Macular Oedema (DMO) This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects. Please see the inside front cover for full details. This booklet has been produced for people who have been prescribed EYLEA (aflibercept solution for injection).

2 Reporting of side effects. This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

Welcome to your EYLEA guide Your doctor has prescribed EYLEA because you have been diagnosed with visual impairment due to diabetic macular oedema, commonly called DMO. This condition is a complication of diabetes that affects your eyesight. Treatments like EYLEA can help stop your eyesight from becoming worse, and may improve some of the symptoms you have. This booklet also contains the Package Leaflet and an audio CD of all the information contained in this book. Whether you read this guide or choose to listen to it on CD, it has been made to help answer any questions you may have, so you can get the most out of your treatment. Your eye care clinic is: Contact: Telephone: Address: Email: 3

Within this book you will find: Information to help you understand DMO What is DMO? What causes DMO? How is DMO treated? What to expect from your EYLEA treatment What is EYLEA? Who is EYLEA for? Why am I being treated with EYLEA? How can I get ready for my EYLEA appointment? What can I expect at my EYLEA appointment? What if I have any concerns or questions? What can I expect after my EYLEA appointment? When do I need to come back for another appointment? How long will my EYLEA treatment last? Are there any side effects with EYLEA? There is also useful information about advice for living with DMO and support groups for people with vision problems. 4

What is DMO? Within the back of your eye, there is a network of tightly woven cells and blood vessels that form a barrier to control substances entering or leaving your retina. The retina is where all of the images you see are processed it acts like the film in a camera. DMO is a condition that damages this barrier, allowing fluid to leak through. This leakage causes swelling of the macular, the part of the retina responsible for central (focal point) and fine vision. When the macular swells with fluid, central vision becomes distorted or blurred. Over time this swelling can create scars that damage your retina. Like scratches on a photograph, these scars make it harder for you to see all that you should. The diagram below shows which areas of your eye are affected by DMO. MACULAR RETINA FOCAL POINT PUPIL OPTIC NERVE IRIS The Macular RETINA LEAKY RETINAL VESSEL 5

What causes DMO? DMO is caused by long-term exposure to high blood sugar levels caused by diabetes. Other things that can increase your risk of worsening DMO are lifestyle factors including over-exposure to direct sunlight, smoking, drinking too much alcohol and being overweight. Quitting smoking greatly lowers the risk of damage to your eyes as well as improving your general health. If you are overweight, losing weight and eating healthily can help protect your eyesight. Your GP can help you with quitting smoking and losing weight. Remember: it is important to follow your eye doctor s advice and to make sure you keep all of your appointments with your doctor, whether for treatment or check-ups. 6

How is visual impairment due to DMO treated? There are several treatment options for DMO and they work in different ways. Generally, these treatments work by shrinking and sealing up the leaking blood vessels and can involve injections or laser therapy. Since no two people are alike, there is no one-size-fits-all solution. Your doctor will choose a treatment best suited to your individual needs. 7

What is EYLEA? EYLEA is a type of treatment known as an anti-vegf, which stands for anti-vascular endothelial growth factor. In DMO, weak blood vessels leak fluid into the eye, causing swelling of the retina. EYLEA can block a particular protein that causes blood vessels in your eye to become leaky. This can help reduce swelling in the retina and protect your vision. EYLEA is a solution (a liquid) that is injected into the eye. While it is understandable to worry about an injection, your doctor will make sure the surface of your eye is numb and so you should feel no more than a little pressure during the procedure. 8

Who is EYLEA for? EYLEA is for people who have been diagnosed with visual impairment due to DMO. Before your treatment starts, make sure to tell your doctor or nurse if you: Have an infection in or around your eye If you currently have redness in your eye or if there is any pain in your eye Think you may be allergic to iodine, any pain killers or any of the ingredients in EYLEA. The full list of ingredients can be found in the attached Package Leaflet Have had any problems with eye injections before Have glaucoma or a history of high pressure in your eye If you see, or have seen, flashes of light or floaters in your vision Are taking any medications, with or without a prescription Are pregnant, planning to become pregnant or breastfeeding. Although there is no experience of using EYLEA in pregnant women, EYLEA should not be used during pregnancy. Please discuss this with your doctor before treatment with EYLEA Women of child-bearing potential should use effective contraception during their treatment and for at least three months after the last injection of EYLEA Had or will have eye surgery within four weeks before or after EYLEA treatment 9

Why am I being treated with EYLEA? EYLEA has been extensively tested in large clinical trials to see how it can help people with visual impairment due to DMO. During these clinical trials, the investigators looked at how well EYLEA works not only to stabilise vision but also improve vision in DMO patients and in some people restore sight that has already been lost. EYLEA was also compared against another treatment, laser photocoagulation that has been used for years in DMO. EYLEA was found to be significantly superior in terms of efficacy and was shown to be an effective treatment for visual impairment due to DMO. The majority of patients found their vision stayed the same or improved and more than 50% found their vision to be significantly improved when compared to before treatment. How well EYLEA works for you will depend on a number of things, such as how long you ve had visual impairment due to DMO and how well you could see before commencing treatment. Your doctor will often have a good idea of how likely you are to respond to EYLEA, and they will discuss this with you at the beginning of the treatment. 10

How can I get ready for my EYLEA appointment? Your doctor may ask you to use eye drops for a few days before your appointment. After your treatment, your vision may be blurred so you should not drive home. Plan to have a friend or family member to take you to your appointment or arrange another way to get there and home again. On the day of your appointment, do not wear any makeup. What can I expect at my EYLEA appointment? Your doctor or nurse will get you ready for your EYLEA treatment. These people are highly trained professionals with experience in treating visual impairment due to DMO. They understand that the treatment procedure may sound worrying so they will take care to make sure you are relaxed and comfortable. You will be given eye drops which numb the front surface of your eye, and an eyewash will be used to clean your eye and the skin around it. During the procedure, your face will be covered by a drape and your eyelids will be held open with a special device to limit any reflex movements, so try not to worry about moving during the procedure. You will be given the injection into the white of your eye. You should feel no more than a little pressure during the procedure. 11

What if I have any concerns or questions? If you have any concerns or questions, your doctor or nurse are the best people to speak to. They are very experienced and they know your individual situation so can provide you with the answers you need. Don t worry about asking questions or voicing any concerns. Your doctor or nurse can give you answers and reassurance. 12

What can I expect after my EYLEA appointment? Your doctor may give you some eye tests after your injection. This may include measuring the pressure inside your eye. After your injection your vision may be blurred, so you should not plan to drive until the next day. Over the next few days you may get a bloodshot eye or see moving spots in your vision. Both of these should improve within days if they don t, or if they get worse, you should contact your doctor. Some people might feel a little bit of pain or discomfort in their eye after their injection. It is advisable to take painkillers that you would normally take for a headache. If the pain does not go away or gets worse, you should contact your doctor. When do I need to come back for another appointment? Your doctor will arrange your next EYLEA appointment with you. Your treatment schedule will be created to best meet your individual needs. Remember, your doctor and nurse are the best people to speak to if you have any questions about your treatment schedule. Speak with your doctor before stopping treatment. 13

How long will my EYLEA treatment last? When you start EYLEA, you will normally have one injection every month for the first five months of treatment, followed by one injection every two months. You will not normally have to come into the hospital between your injections. After you have been on EYLEA for one year, your eye doctor may decide you can wait longer than two months between injections, depending on your eyesight and the results of other tests on your eye. If this happens, your doctor will decide whether or not you need any extra check-ups between your injection visits. If at any point your doctor thinks you are not getting any benefit from EYLEA, your treatment will stop. During treatment, it is important to keep all your appointments so that your treatment is given every opportunity to work as effectively as possible. If for any reason you can t attend an appointment, please contact your eye clinic as soon as possible to arrange a new time. 14

Are there any side effects with EYLEA? Just like all medicines, whether by prescription or over the counter, EYLEA has the potential to cause side effects. Not everyone who takes EYLEA will experience a side effect. The most common side effects are: Bloodshot eye Eye pain Increase in eye pressure The gel-like substance inside the eye pulling away from the retina. This isn t usually sight threatening Moving spots in vision Clouding of the lens (cataract) Some side effects may be serious and include: Clouding of the lens (cataract) Retinal detachment Infection/inflammation inside the eye Temporary increase of pressure inside the eye In clinical studies, these serious side effects only occurred once in every 2,600 injections. Contact your doctor as soon as possible if you experience any increased eye pain, if the redness gets worse, if your vision gets more blurred or you can t see as well as usual, if you become more sensitive to light or if you experience the sudden appearance of floaters, flashes of light and/or obscured vision. For a full list of side effects, refer to the attached Package Leaflet. If you think you might have a side effect from your treatment, speak to your doctor. 15

Advice for living with DMO Being diagnosed with DMO and experiencing problems with your eyesight can be an anxious time. It is normal to worry and feel uncertain about your future, but your diagnosis doesn t mean you can no longer live a full life. You can continue to enjoy family, friends and interests with some small changes. Some helpful advice includes: Tell friends and family that you have DMO and that it affects your eyesight Use brighter lighting Organise your surroundings so it is easier to find things Use magnifying lenses with built in lights when needed. Take them with you when you go out Read large print books and newspapers and try audio books or computers with large print settings For more helpful tips on living with DMO, please see the information about support groups on the following pages. Support for people with DMO However much you are affected by DMO, it is important to remember that you are not alone. It may be difficult to understand your diagnosis or to come to terms with it. Speaking to experts can help answer questions you may have, while speaking to others who are in, or have been in, a similar situation to yourself can help you come to terms with your diagnosis. 16

Where can you find out more about DMO? If you would like to find out more, or even be put in touch with other people suffering from DMO, a list of useful contacts can be found below. You can write to these organisations, phone them or, if you have access to the internet, go to their websites. Many of these organisations will have downloadable files of information which can be printed or read on the screen. They may also be able to provide their information in audio format for you to listen to. The Macular Society Helpline: 0300 3030 111 Address: The Macular Society, PO Box 1870, Andover SP10 9AD Email: info@macularsociety.org Website: www.macularsociety.org RNIB (Royal National Institute of Blind People) Telephone: 0303 123 9999 Address: RNIB Headquarters, 105 Judd Street, London WC1H 9NE Email: helpline@rnib.org.uk Website: www.rnib.org.uk Diabetes UK Telephone: 0345 123 2399 Address: Macleod House, 10 Parkway, London NW1 7AA Email: info@diabetes.org.uk Website: www.diabetes.org.uk This guide has been reviewed by the RNIB and Diabetes UK. 17

18 Notes

Audio guide to EYLEA CD WALLET PLACEHOLDER 19

Bayer plc, Bayer House, Strawberry Hill, Newbury, Berkshire RG14 1JA. Tel: (01635) 563000 medical.information@bayer.co.uk. Bayer plc August 2014. Registered trademark of Bayer AG, Germany. Date of preparation: August 2014. Code.no. L.GB.08.2014.7473 aflibercept solution for injection EYLEA is used to treat visual impairment due to Diabetic Macular Oedema (DMO)